 | • レポートコード：GIR-2104Z04701 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、薬剤溶出性生体吸収性ステントのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。薬剤溶出性生体吸収性ステントの種類別市場規模（セロリムス・パクリタキセル薬剤溶出ステント、シロリムス薬剤溶出ステント）、用途別市場規模（冠状動脈疾患、末梢動脈疾患）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・薬剤溶出性生体吸収性ステントの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Medtronic、B.Braun Melsungen、Abbott Laboratories、Boston Scientific Corporation、Biosensors International、Terumo Corporation.、MicroPort Scientific Corporation、Alvimedica、Biotronik、Elixir Medical Corporation、Innovative Health Technologies ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：セロリムス・パクリタキセル薬剤溶出ステント、シロリムス薬剤溶出ステント ・用途別分析2016年-2026年：冠状動脈疾患、末梢動脈疾患 ・薬剤溶出性生体吸収性ステントの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・薬剤溶出性生体吸収性ステントのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・薬剤溶出性生体吸収性ステントのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・薬剤溶出性生体吸収性ステントの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・薬剤溶出性生体吸収性ステントの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Drug-Eluting Bioabsorbable Stents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Drug-Eluting Bioabsorbable Stents size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Drug-Eluting Bioabsorbable Stents market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Drug-Eluting Bioabsorbable Stents market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Serolimus and Paclitaxel Drug-Eluting Stents
Sirolimus Drug Eluting Stents
Market segment by Application can be divided into
Coronary Artery Diseases
Peripheral Artery Diseases
The key market players for global Drug-Eluting Bioabsorbable Stents market are listed below:
Medtronic
B.Braun Melsungen
Abbott Laboratories
Boston Scientific Corporation
Biosensors International
Terumo Corporation.
MicroPort Scientific Corporation
Alvimedica
Biotronik
Elixir Medical Corporation
Innovative Health Technologies
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Drug-Eluting Bioabsorbable Stents Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Drug-Eluting Bioabsorbable Stents Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Serolimus and Paclitaxel Drug-Eluting Stents
1.2.3 Sirolimus Drug Eluting Stents
1.3 Market Analysis by Application
1.3.1 Overview: Global Drug-Eluting Bioabsorbable Stents Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Coronary Artery Diseases
1.3.3 Peripheral Artery Diseases
1.4 Global Drug-Eluting Bioabsorbable Stents Market Size & Forecast
1.4.1 Global Drug-Eluting Bioabsorbable Stents Sales in Value (2016-2026))
1.4.2 Global Drug-Eluting Bioabsorbable Stents Sales in Volume (2016-2026)
1.4.3 Global Drug-Eluting Bioabsorbable Stents Price by Type (2016-2026) & (USD/Unit)
1.5 Global Drug-Eluting Bioabsorbable Stents Production Capacity Analysis
1.5.1 Global Drug-Eluting Bioabsorbable Stents Total Production Capacity (2016-2026)
1.5.2 Global Drug-Eluting Bioabsorbable Stents Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Drug-Eluting Bioabsorbable Stents Market Drivers
1.6.2 Drug-Eluting Bioabsorbable Stents Market Restraints
1.6.3 Drug-Eluting Bioabsorbable Stents Trends Analysis
2 Manufacturers Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Drug-Eluting Bioabsorbable Stents Product and Services
2.1.4 Medtronic Drug-Eluting Bioabsorbable Stents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 B.Braun Melsungen
2.2.1 B.Braun Melsungen Details
2.2.2 B.Braun Melsungen Major Business
2.2.3 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Product and Services
2.2.4 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Abbott Laboratories
2.3.1 Abbott Laboratories Details
2.3.2 Abbott Laboratories Major Business
2.3.3 Abbott Laboratories Drug-Eluting Bioabsorbable Stents Product and Services
2.3.4 Abbott Laboratories Drug-Eluting Bioabsorbable Stents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Boston Scientific Corporation
2.4.1 Boston Scientific Corporation Details
2.4.2 Boston Scientific Corporation Major Business
2.4.3 Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Product and Services
2.4.4 Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Biosensors International
2.5.1 Biosensors International Details
2.5.2 Biosensors International Major Business
2.5.3 Biosensors International Drug-Eluting Bioabsorbable Stents Product and Services
2.5.4 Biosensors International Drug-Eluting Bioabsorbable Stents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Terumo Corporation.
2.6.1 Terumo Corporation. Details
2.6.2 Terumo Corporation. Major Business
2.6.3 Terumo Corporation. Drug-Eluting Bioabsorbable Stents Product and Services
2.6.4 Terumo Corporation. Drug-Eluting Bioabsorbable Stents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 MicroPort Scientific Corporation
2.7.1 MicroPort Scientific Corporation Details
2.7.2 MicroPort Scientific Corporation Major Business
2.7.3 MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Product and Services
2.7.4 MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Alvimedica
2.8.1 Alvimedica Details
2.8.2 Alvimedica Major Business
2.8.3 Alvimedica Drug-Eluting Bioabsorbable Stents Product and Services
2.8.4 Alvimedica Drug-Eluting Bioabsorbable Stents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Biotronik
2.9.1 Biotronik Details
2.9.2 Biotronik Major Business
2.9.3 Biotronik Drug-Eluting Bioabsorbable Stents Product and Services
2.9.4 Biotronik Drug-Eluting Bioabsorbable Stents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Elixir Medical Corporation
2.10.1 Elixir Medical Corporation Details
2.10.2 Elixir Medical Corporation Major Business
2.10.3 Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Product and Services
2.10.4 Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Innovative Health Technologies
2.11.1 Innovative Health Technologies Details
2.11.2 Innovative Health Technologies Major Business
2.11.3 Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Product and Services
2.11.4 Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Drug-Eluting Bioabsorbable Stents Sales by Manufacturer
3.1 Global Drug-Eluting Bioabsorbable Stents Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Drug-Eluting Bioabsorbable Stents Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Drug-Eluting Bioabsorbable Stents
3.4 Market Concentration Rate
3.4.1 Top 3 Drug-Eluting Bioabsorbable Stents Manufacturer Market Share
3.4.2 Top 6 Drug-Eluting Bioabsorbable Stents Manufacturer Market Share
3.5 Global Drug-Eluting Bioabsorbable Stents Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Drug-Eluting Bioabsorbable Stents Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Drug-Eluting Bioabsorbable Stents Market Size by Region
4.1.1 Global Drug-Eluting Bioabsorbable Stents Sales in Volume by Region (2016-2026)
4.1.2 Global Drug-Eluting Bioabsorbable Stents Revenue by Region (2016-2026)
4.2 North America Drug-Eluting Bioabsorbable Stents Revenue (2016-2026)
4.3 Europe Drug-Eluting Bioabsorbable Stents Revenue (2016-2026)
4.4 Asia-Pacific Drug-Eluting Bioabsorbable Stents Revenue (2016-2026)
4.5 South America Drug-Eluting Bioabsorbable Stents Revenue (2016-2026)
4.6 Middle East and Africa Drug-Eluting Bioabsorbable Stents Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Drug-Eluting Bioabsorbable Stents Sales in Volume by Type (2016-2026)
5.2 Global Drug-Eluting Bioabsorbable Stents Revenue by Type (2016-2026)
5.3 Global Drug-Eluting Bioabsorbable Stents Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Drug-Eluting Bioabsorbable Stents Sales in Volume by Application (2016-2026)
6.2 Global Drug-Eluting Bioabsorbable Stents Revenue by Application (2016-2026)
6.3 Global Drug-Eluting Bioabsorbable Stents Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Drug-Eluting Bioabsorbable Stents Sales by Type (2016-2026)
7.2 North America Drug-Eluting Bioabsorbable Stents Sales by Application (2016-2026)
7.3 North America Drug-Eluting Bioabsorbable Stents Market Size by Country
7.3.1 North America Drug-Eluting Bioabsorbable Stents Sales in Volume by Country (2016-2026)
7.3.2 North America Drug-Eluting Bioabsorbable Stents Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Drug-Eluting Bioabsorbable Stents Sales by Type (2016-2026)
8.2 Europe Drug-Eluting Bioabsorbable Stents Sales by Application (2016-2026)
8.3 Europe Drug-Eluting Bioabsorbable Stents Market Size by Country
8.3.1 Europe Drug-Eluting Bioabsorbable Stents Sales in Volume by Country (2016-2026)
8.3.2 Europe Drug-Eluting Bioabsorbable Stents Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Drug-Eluting Bioabsorbable Stents Sales by Type (2016-2026)
9.2 Asia-Pacific Drug-Eluting Bioabsorbable Stents Sales by Application (2016-2026)
9.3 Asia-Pacific Drug-Eluting Bioabsorbable Stents Market Size by Region
9.3.1 Asia-Pacific Drug-Eluting Bioabsorbable Stents Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Drug-Eluting Bioabsorbable Stents Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Drug-Eluting Bioabsorbable Stents Sales by Type (2016-2026)
10.2 South America Drug-Eluting Bioabsorbable Stents Sales by Application (2016-2026)
10.3 South America Drug-Eluting Bioabsorbable Stents Market Size by Country
10.3.1 South America Drug-Eluting Bioabsorbable Stents Sales in Volume by Country (2016-2026)
10.3.2 South America Drug-Eluting Bioabsorbable Stents Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales by Type (2016-2026)
11.2 Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales by Application (2016-2026)
11.3 Middle East & Africa Drug-Eluting Bioabsorbable Stents Market Size by Country
11.3.1 Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Drug-Eluting Bioabsorbable Stents Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Drug-Eluting Bioabsorbable Stents Typical Distributors
12.3 Drug-Eluting Bioabsorbable Stents Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Drug-Eluting Bioabsorbable Stents Revenue by Type, (USD Million), 2021-2026
Table 2. Global Drug-Eluting Bioabsorbable Stents Revenue by Application, (USD Million), 2021-2026
Table 3. Medtronic Basic Information, Manufacturing Base and Competitors
Table 4. Medtronic Major Business
Table 5. Medtronic Drug-Eluting Bioabsorbable Stents Product and Services
Table 6. Medtronic Drug-Eluting Bioabsorbable Stents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. B.Braun Melsungen Basic Information, Manufacturing Base and Competitors
Table 8. B.Braun Melsungen Major Business
Table 9. B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Product and Services
Table 10. B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 12. Abbott Laboratories Major Business
Table 13. Abbott Laboratories Drug-Eluting Bioabsorbable Stents Product and Services
Table 14. Abbott Laboratories Drug-Eluting Bioabsorbable Stents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 16. Boston Scientific Corporation Major Business
Table 17. Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Product and Services
Table 18. Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Biosensors International Basic Information, Manufacturing Base and Competitors
Table 20. Biosensors International Major Business
Table 21. Biosensors International Drug-Eluting Bioabsorbable Stents Product and Services
Table 22. Biosensors International Drug-Eluting Bioabsorbable Stents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Terumo Corporation. Basic Information, Manufacturing Base and Competitors
Table 24. Terumo Corporation. Major Business
Table 25. Terumo Corporation. Drug-Eluting Bioabsorbable Stents Product and Services
Table 26. Terumo Corporation. Drug-Eluting Bioabsorbable Stents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. MicroPort Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 28. MicroPort Scientific Corporation Major Business
Table 29. MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Product and Services
Table 30. MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Alvimedica Basic Information, Manufacturing Base and Competitors
Table 32. Alvimedica Major Business
Table 33. Alvimedica Drug-Eluting Bioabsorbable Stents Product and Services
Table 34. Alvimedica Drug-Eluting Bioabsorbable Stents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Biotronik Basic Information, Manufacturing Base and Competitors
Table 36. Biotronik Major Business
Table 37. Biotronik Drug-Eluting Bioabsorbable Stents Product and Services
Table 38. Biotronik Drug-Eluting Bioabsorbable Stents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Elixir Medical Corporation Basic Information, Manufacturing Base and Competitors
Table 40. Elixir Medical Corporation Major Business
Table 41. Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Product and Services
Table 42. Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Innovative Health Technologies Basic Information, Manufacturing Base and Competitors
Table 44. Innovative Health Technologies Major Business
Table 45. Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Product and Services
Table 46. Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Global Drug-Eluting Bioabsorbable Stents Sales by Manufacturer (2019-2021e) & (K Units)
Table 48. Global Drug-Eluting Bioabsorbable Stents Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 49. Market Position of Manufacturers in Drug-Eluting Bioabsorbable Stents, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 50. Global Drug-Eluting Bioabsorbable Stents Production Capacity by Company, (K Units): 2020 VS 2021
Table 51. Head Office and Drug-Eluting Bioabsorbable Stents Production Site of Key Manufacturer
Table 52. Global Drug-Eluting Bioabsorbable Stents Sales by Region (2016-2021e) & (K Units)
Table 53. Global Drug-Eluting Bioabsorbable Stents Sales by Region (2021-2026) & (K Units)
Table 54. Global Drug-Eluting Bioabsorbable Stents Revenue by Region (2016-2021e) & (USD Million)
Table 55. Global Drug-Eluting Bioabsorbable Stents Revenue by Region (2021-2026) & (USD Million)
Table 56. Global Drug-Eluting Bioabsorbable Stents Sales by Type (2016-2021e) & (K Units)
Table 57. Global Drug-Eluting Bioabsorbable Stents Sales by Type (2021-2026) & (K Units)
Table 58. Global Drug-Eluting Bioabsorbable Stents Revenue by Type (2016-2021e) & (USD Million)
Table 59. Global Drug-Eluting Bioabsorbable Stents Revenue by Type (2021-2026) & (USD Million)
Table 60. Global Drug-Eluting Bioabsorbable Stents Price by Type (2016-2021e) & (USD/Unit)
Table 61. Global Drug-Eluting Bioabsorbable Stents Price by Type (2021-2026) & (USD/Unit)
Table 62. Global Drug-Eluting Bioabsorbable Stents Sales by Application (2016-2021e) & (K Units)
Table 63. Global Drug-Eluting Bioabsorbable Stents Sales by Application (2021-2026) & (K Units)
Table 64. Global Drug-Eluting Bioabsorbable Stents Revenue by Application (2016-2021e) & (USD Million)
Table 65. Global Drug-Eluting Bioabsorbable Stents Revenue by Application (2021-2026) & (USD Million)
Table 66. Global Drug-Eluting Bioabsorbable Stents Price by Application (2016-2021e) & (USD/Unit)
Table 67. Global Drug-Eluting Bioabsorbable Stents Price by Application (2021-2026) & (USD/Unit)
Table 68. North America Drug-Eluting Bioabsorbable Stents Sales by Country (2016-2021e) & (K Units)
Table 69. North America Drug-Eluting Bioabsorbable Stents Sales by Country (2021-2026) & (K Units)
Table 70. North America Drug-Eluting Bioabsorbable Stents Revenue by Country (2016-2021e) & (USD Million)
Table 71. North America Drug-Eluting Bioabsorbable Stents Revenue by Country (2021-2026) & (USD Million)
Table 72. North America Drug-Eluting Bioabsorbable Stents Sales by Type (2016-2021e) & (K Units)
Table 73. North America Drug-Eluting Bioabsorbable Stents Sales by Type (2021-2026) & (K Units)
Table 74. North America Drug-Eluting Bioabsorbable Stents Sales by Application (2016-2021e) & (K Units)
Table 75. North America Drug-Eluting Bioabsorbable Stents Sales by Application (2021-2026) & (K Units)
Table 76. Europe Drug-Eluting Bioabsorbable Stents Sales by Country (2016-2021e) & (K Units)
Table 77. Europe Drug-Eluting Bioabsorbable Stents Sales by Country (2021-2026) & (K Units)
Table 78. Europe Drug-Eluting Bioabsorbable Stents Revenue by Country (2016-2021e) & (USD Million)
Table 79. Europe Drug-Eluting Bioabsorbable Stents Revenue by Country (2021-2026) & (USD Million)
Table 80. Europe Drug-Eluting Bioabsorbable Stents Sales by Type (2016-2021e) & (K Units)
Table 81. Europe Drug-Eluting Bioabsorbable Stents Sales by Type (2021-2026) & (K Units)
Table 82. Europe Drug-Eluting Bioabsorbable Stents Sales by Application (2016-2021e) & (K Units)
Table 83. Europe Drug-Eluting Bioabsorbable Stents Sales by Application (2021-2026) & (K Units)
Table 84. Asia-Pacific Drug-Eluting Bioabsorbable Stents Sales by Region (2016-2021e) & (K Units)
Table 85. Asia-Pacific Drug-Eluting Bioabsorbable Stents Sales by Region (2021-2026) & (K Units)
Table 86. Asia-Pacific Drug-Eluting Bioabsorbable Stents Revenue by Region (2016-2021e) & (USD Million)
Table 87. Asia-Pacific Drug-Eluting Bioabsorbable Stents Revenue by Region (2021-2026) & (USD Million)
Table 88. Asia-Pacific Drug-Eluting Bioabsorbable Stents Sales by Type (2016-2021e) & (K Units)
Table 89. Asia-Pacific Drug-Eluting Bioabsorbable Stents Sales by Type (2021-2026) & (K Units)
Table 90. Asia-Pacific Drug-Eluting Bioabsorbable Stents Sales by Application (2016-2021e) & (K Units)
Table 91. Asia-Pacific Drug-Eluting Bioabsorbable Stents Sales by Application (2021-2026) & (K Units)
Table 92. South America Drug-Eluting Bioabsorbable Stents Sales by Country (2016-2021e) & (K Units)
Table 93. South America Drug-Eluting Bioabsorbable Stents Sales by Country (2021-2026) & (K Units)
Table 94. South America Drug-Eluting Bioabsorbable Stents Revenue by Country (2016-2021e) & (USD Million)
Table 95. South America Drug-Eluting Bioabsorbable Stents Revenue by Country (2021-2026) & (USD Million)
Table 96. South America Drug-Eluting Bioabsorbable Stents Sales by Type (2016-2021e) & (K Units)
Table 97. South America Drug-Eluting Bioabsorbable Stents Sales by Type (2021-2026) & (K Units)
Table 98. South America Drug-Eluting Bioabsorbable Stents Sales by Application (2016-2021e) & (K Units)
Table 99. South America Drug-Eluting Bioabsorbable Stents Sales by Application (2021-2026) & (K Units)
Table 100. Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales by Country (2016-2021e) & (K Units)
Table 101. Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales by Country (2021-2026) & (K Units)
Table 102. Middle East & Africa Drug-Eluting Bioabsorbable Stents Revenue by Country (2016-2021e) & (USD Million)
Table 103. Middle East & Africa Drug-Eluting Bioabsorbable Stents Revenue by Country (2021-2026) & (USD Million)
Table 104. Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales by Type (2016-2021e) & (K Units)
Table 105. Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales by Type (2021-2026) & (K Units)
Table 106. Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales by Application (2016-2021e) & (K Units)
Table 107. Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales by Application (2021-2026) & (K Units)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Drug-Eluting Bioabsorbable Stents Typical Distributors
Table 111. Drug-Eluting Bioabsorbable Stents Typical Customers
List of Figures
Figure 1. Drug-Eluting Bioabsorbable Stents Picture
Figure 2. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Type in 2020
Figure 3. Serolimus and Paclitaxel Drug-Eluting Stents
Figure 4. Sirolimus Drug Eluting Stents
Figure 5. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Application in 2020
Figure 6. Coronary Artery Diseases
Figure 7. Peripheral Artery Diseases
Figure 8. Global Drug-Eluting Bioabsorbable Stents Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 9. Global Drug-Eluting Bioabsorbable Stents Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. United States Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 11. Canada Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Mexico Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Germany Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. France Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. United Kingdom Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Russia Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Italy Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. China Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Japan Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Korea Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. India Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Southeast Asia Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Australia Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Brazil Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Egypt Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Saudi Arabia Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. South Africa Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Turkey Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Global Drug-Eluting Bioabsorbable Stents Sales (2016-2026) & (K Units)
Figure 30. Global Drug-Eluting Bioabsorbable Stents Production Capacity (2016-2026) & (K Units)
Figure 31. Global Drug-Eluting Bioabsorbable Stents Production Capacity by Geographic Region: 2020 VS 2021
Figure 32. Drug-Eluting Bioabsorbable Stents Market Drivers
Figure 33. Drug-Eluting Bioabsorbable Stents Market Restraints
Figure 34. Drug-Eluting Bioabsorbable Stents Market Trends
Figure 35. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Manufacturer in 2020
Figure 36. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Manufacturer in 2020
Figure 37. Drug-Eluting Bioabsorbable Stents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 38. Top 3 Drug-Eluting Bioabsorbable Stents Manufacturer (Revenue) Market Share in 2020
Figure 39. Top 6 Drug-Eluting Bioabsorbable Stents Manufacturer (Revenue) Market Share in 2020
Figure 40. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Region (2016-2026)
Figure 41. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Region (2016-2026)
Figure 42. North America Drug-Eluting Bioabsorbable Stents Revenue (2016-2026) & (USD Million)
Figure 43. Europe Drug-Eluting Bioabsorbable Stents Revenue (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Drug-Eluting Bioabsorbable Stents Revenue (2016-2026) & (USD Million)
Figure 45. South America Drug-Eluting Bioabsorbable Stents Revenue (2016-2026) & (USD Million)
Figure 46. Middle East & Africa Drug-Eluting Bioabsorbable Stents Revenue (2016-2026) & (USD Million)
Figure 47. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2016-2026)
Figure 48. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Type (2016-2026)
Figure 49. Global Drug-Eluting Bioabsorbable Stents Price by Type (2016-2026) & (USD/Unit)
Figure 50. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2016-2026)
Figure 51. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Application (2016-2026)
Figure 52. Global Drug-Eluting Bioabsorbable Stents Price by Application (2016-2026) & (USD/Unit)
Figure 53. North America Drug-Eluting Bioabsorbable Stents Sales Market Share by Country (2016-2026)
Figure 54. North America Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country (2016-2026)
Figure 55. North America Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2016-2026)
Figure 56. North America Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2016-2026)
Figure 57. Europe Drug-Eluting Bioabsorbable Stents Sales Market Share by Country (2016-2026)
Figure 58. Europe Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country (2016-2026)
Figure 59. Europe Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2016-2026)
Figure 60. Europe Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Drug-Eluting Bioabsorbable Stents Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Drug-Eluting Bioabsorbable Stents Revenue Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Drug-Eluting Bioabsorbable Stents Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2016-2026)
Figure 65. South America Drug-Eluting Bioabsorbable Stents Sales Market Share by Country (2016-2026)
Figure 66. South America Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country (2016-2026)
Figure 67. South America Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2016-2026)
Figure 68. South America Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2016-2026)
Figure 73. Sales Channel: Direct Channel vs Indirect Channel
Figure 74. Methodology
Figure 75. Research Process and Data Source
世界の薬剤溶出性ステント（DES）市場 2021：企業別、地域別、種類・用途別 The Drug Eluting Stents (DES) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…- 世界の生体吸収性血管ステント市場 2021：企業別、地域別、種類・用途別 The Bioabsorbable Vascular Stents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界のバルーン血管形成術・心臓ステント市場規模・現状・予測（2021年-2027年） Balloon angioplasty is a minimally invasive cardiac catheterization procedure used to open narrow and blocked arteries. Heart stents are tiny lattice-shaped metal tubes that serve as scaffolding to keep the artery open. Market Analysis and Insights: Global Balloon Angioplasty and Heart Stents Market…
- 世界のバルーン血管形成術・心臓ステント市場規模・現状・予測（2021年-2027年） Balloon angioplasty is a minimally invasive cardiac catheterization procedure used to open narrow and blocked arteries. Heart stents are tiny lattice-shaped metal tubes that serve as scaffolding to keep the artery open. Market Analysis and Insights: Global Balloon Angioplasty and Heart Stents Market…
- 世界の生体吸収性冠動脈ステント市場規模・現状・予測（2021年-2027年） Placement of these bioresorbable devices enable individuals to live with a normal functioning artery as well as the option to undergo an angioplasty in their later years. While still in development stage, the pediatric patient cohort with genetic coronary conditions are a viable target for these ful…